Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach

Heterocyclic ureas, such as N-3-thienyl N′-aryl ureas, have been identified as novel inhibitors of raf kinase, a key mediator in the ras signal transduction pathway. Structure–activity relationships were established, and the potency of the screening hit was improved 10-fold to IC 50=1.7 μM. A combin...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 11; no. 20; pp. 2775 - 2778
Main Authors: Smith, Roger A, Barbosa, James, Blum, Cheri L, Bobko, Mark A, Caringal, Yolanda V, Dally, Robert, Johnson, Jeffrey S, Katz, Michael E, Kennure, Nancy, Kingery-Wood, Jill, Lee, Wendy, Lowinger, Timothy B, Lyons, John, Marsh, Vivienne, Rogers, Daniel H, Swartz, Stephen, Walling, Tracy, Wild, Hanno
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 22-10-2001
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Heterocyclic ureas, such as N-3-thienyl N′-aryl ureas, have been identified as novel inhibitors of raf kinase, a key mediator in the ras signal transduction pathway. Structure–activity relationships were established, and the potency of the screening hit was improved 10-fold to IC 50=1.7 μM. A combinatorial synthesis approach enabled the identification of a breakthrough lead (IC 50=0.54 μM) for a second generation series of heterocyclic urea raf kinase inhibitors. Heterocyclic ureas have been identified as novel inhibitors of raf kinase, and structure–activity relationships were established. The potency of the screening hit was improved 10-fold to IC 50=1.7 μM, whereas a combinatorial synthesis approach enabled the identification of a breakthrough lead (IC 50=0.54 μM) for a second generation series of inhibitors.
AbstractList Heterocyclic ureas, such as N-3-thienyl N′-aryl ureas, have been identified as novel inhibitors of raf kinase, a key mediator in the ras signal transduction pathway. Structure–activity relationships were established, and the potency of the screening hit was improved 10-fold to IC 50=1.7 μM. A combinatorial synthesis approach enabled the identification of a breakthrough lead (IC 50=0.54 μM) for a second generation series of heterocyclic urea raf kinase inhibitors. Heterocyclic ureas have been identified as novel inhibitors of raf kinase, and structure–activity relationships were established. The potency of the screening hit was improved 10-fold to IC 50=1.7 μM, whereas a combinatorial synthesis approach enabled the identification of a breakthrough lead (IC 50=0.54 μM) for a second generation series of inhibitors.
Heterocyclic ureas, such as N-3-thienyl N'-aryl ureas, have been identified as novel inhibitors of raf kinase, a key mediator in the ras signal transduction pathway. Structure-activity relationships were established, and the potency of the screening hit was improved 10-fold to IC(50)=1.7 microM. A combinatorial synthesis approach enabled the identification of a breakthrough lead (IC(50)=0.54 microM) for a second generation series of heterocyclic urea raf kinase inhibitors.
Author Kennure, Nancy
Lowinger, Timothy B
Blum, Cheri L
Wild, Hanno
Marsh, Vivienne
Kingery-Wood, Jill
Caringal, Yolanda V
Dally, Robert
Rogers, Daniel H
Katz, Michael E
Smith, Roger A
Barbosa, James
Swartz, Stephen
Lyons, John
Walling, Tracy
Johnson, Jeffrey S
Bobko, Mark A
Lee, Wendy
Author_xml – sequence: 1
  givenname: Roger A
  surname: Smith
  fullname: Smith, Roger A
  email: roger.smith.b@bayer.com
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 2
  givenname: James
  surname: Barbosa
  fullname: Barbosa, James
  organization: Department of Cancer Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 3
  givenname: Cheri L
  surname: Blum
  fullname: Blum, Cheri L
  organization: Onyx Pharmaceuticals, 3031 Research Drive, Richmond, CA 94806, USA
– sequence: 4
  givenname: Mark A
  surname: Bobko
  fullname: Bobko, Mark A
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 5
  givenname: Yolanda V
  surname: Caringal
  fullname: Caringal, Yolanda V
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 6
  givenname: Robert
  surname: Dally
  fullname: Dally, Robert
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 7
  givenname: Jeffrey S
  surname: Johnson
  fullname: Johnson, Jeffrey S
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 8
  givenname: Michael E
  surname: Katz
  fullname: Katz, Michael E
  organization: Department of Cancer Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 9
  givenname: Nancy
  surname: Kennure
  fullname: Kennure, Nancy
  organization: Department of Cancer Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 10
  givenname: Jill
  surname: Kingery-Wood
  fullname: Kingery-Wood, Jill
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 11
  givenname: Wendy
  surname: Lee
  fullname: Lee, Wendy
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 12
  givenname: Timothy B
  surname: Lowinger
  fullname: Lowinger, Timothy B
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 13
  givenname: John
  surname: Lyons
  fullname: Lyons, John
  organization: Onyx Pharmaceuticals, 3031 Research Drive, Richmond, CA 94806, USA
– sequence: 14
  givenname: Vivienne
  surname: Marsh
  fullname: Marsh, Vivienne
  organization: Onyx Pharmaceuticals, 3031 Research Drive, Richmond, CA 94806, USA
– sequence: 15
  givenname: Daniel H
  surname: Rogers
  fullname: Rogers, Daniel H
  organization: Onyx Pharmaceuticals, 3031 Research Drive, Richmond, CA 94806, USA
– sequence: 16
  givenname: Stephen
  surname: Swartz
  fullname: Swartz, Stephen
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 17
  givenname: Tracy
  surname: Walling
  fullname: Walling, Tracy
  organization: Department of Cancer Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 18
  givenname: Hanno
  surname: Wild
  fullname: Wild, Hanno
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14083583$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11591521$$D View this record in MEDLINE/PubMed
BookMark eNqFkc-KFDEQxoOsuLOrj6DkoqyH1qQ7SXd7Edn1Hyx4UMFbqK5UO9GeZEx6VuZRfFvTO4N7FAoCld9X9VHfGTsJMRBjj6V4IYU0Lz-L3oiq69W3CyGfC6FbWZl7bCWVUVWjhD5hq3_IKTvL-YcQUgmlHrBTKXUvdS1X7M-VzxhvKO15HPmaZkoR9zh55LtEkPlSPNBvjhPkvEAJRv7TB8jEfVj7wc8x5VfcOwqzHz3C7GNYQOCZMAbHv1OgdGhPBI4P-_KHcTOUKUXsYeK4po3Pc7EB222KgOuH7P4IU6ZHx_ecfX339svlh-r60_uPl2-uK1S6nSsYunpopBbgUOvWCA3Kyb4eFLUGVU9DS7JTUtQNKKpJK6fJ1J1TDWnTt805e3aYW9b-2lGebTGCNE0QKO6ybesiN1IWUB9ATDHnRKPdJr-BtLdS2CUTe5uJXQ5uhbS3mVhTdE-OC3bDhtyd6hhCAZ4eAcgI05ggoM93nBJdo7umcK8PHJVz3HhKNqOngOR8Ipyti_4_Vv4CE_ytFA
CitedBy_id crossref_primary_10_1016_j_bmcl_2008_02_068
crossref_primary_10_1134_S1070428016110191
crossref_primary_10_2174_1570180816666190130154726
crossref_primary_10_1111_j_1872_034X_2012_01113_x
crossref_primary_10_1002_pauz_200800277
crossref_primary_10_1039_C4RA13819H
crossref_primary_10_1016_j_bioorg_2019_01_040
crossref_primary_10_1021_ol101704r
crossref_primary_10_1016_S1367_5931_03_00059_0
crossref_primary_10_1517_17460441_2015_1006194
crossref_primary_10_1055_a_2157_5855
crossref_primary_10_1016_S0960_894X_01_00571_6
crossref_primary_10_1134_S1070363222100176
crossref_primary_10_1016_j_bbapap_2003_11_028
crossref_primary_10_1016_S1359_6446_03_03007_1
crossref_primary_10_1002_adsc_201701124
crossref_primary_10_1002_jccs_201000040
crossref_primary_10_5012_bkcs_2009_30_9_2027
crossref_primary_10_1517_13543784_2012_665872
crossref_primary_10_1038_s41392_023_01460_1
crossref_primary_10_1080_10426507_2010_534521
crossref_primary_10_1016_S0040_4039_02_02656_4
crossref_primary_10_1038_nrd2130
crossref_primary_10_1016_j_ejmech_2016_01_057
crossref_primary_10_1080_00397911_2011_632831
crossref_primary_10_1134_S1070428014110219
crossref_primary_10_3389_fchem_2022_995351
crossref_primary_10_1021_jm5009242
crossref_primary_10_3987_REV_10_SR_E_3
crossref_primary_10_1021_jm200349b
crossref_primary_10_3987_REV_06_SR_W_1
crossref_primary_10_1016_j_bmcl_2003_11_041
crossref_primary_10_1016_j_poly_2012_12_016
crossref_primary_10_1016_j_tet_2005_12_065
crossref_primary_10_1002_chin_200204122
crossref_primary_10_1134_S1070428015080102
crossref_primary_10_1517_17460441_2014_924923
crossref_primary_10_1016_j_bmcl_2011_04_023
crossref_primary_10_1620_tjem_237_173
crossref_primary_10_5012_bkcs_2008_29_11_2231
crossref_primary_10_1016_j_tet_2012_11_041
crossref_primary_10_1002_cmdc_202300535
crossref_primary_10_1586_17446651_2014_960391
crossref_primary_10_1021_acs_chemrev_5b00392
crossref_primary_10_1016_j_cplett_2008_07_010
crossref_primary_10_1021_acs_jmedchem_0c02167
crossref_primary_10_1016_j_jmgm_2013_12_008
crossref_primary_10_5155_eurjchem_3_4_442_446_691
crossref_primary_10_1007_s10593_015_1664_y
crossref_primary_10_1039_C2MD20291C
crossref_primary_10_1021_jm801050k
crossref_primary_10_1016_j_ejmech_2007_10_008
crossref_primary_10_1016_j_molstruc_2011_01_011
crossref_primary_10_1016_j_bmcl_2011_12_112
crossref_primary_10_1134_S1070363216070094
crossref_primary_10_1002_qsar_200420043
crossref_primary_10_1246_bcsj_20090318
crossref_primary_10_3390_ph6080988
crossref_primary_10_2165_11593320_000000000_00000
Cites_doi 10.1016/S0960-894X(00)00272-9
10.1016/S0960-894X(99)00668-X
10.1128/MCB.13.11.6615
10.1016/S0960-894X(00)00574-6
10.1517/13543776.8.12.1749
10.1038/nm0696-668
10.1016/S0960-894X(01)00571-6
10.1007/978-3-642-60393-8_16
10.1016/S0960-894X(00)00270-5
10.1146/annurev.bi.62.070193.004223
10.1517/13543776.11.3.405
ContentType Journal Article
Copyright 2001 Elsevier Science Ltd
2002 INIST-CNRS
Copyright_xml – notice: 2001 Elsevier Science Ltd
– notice: 2002 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/S0960-894X(01)00571-6
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3405
EndPage 2778
ExternalDocumentID 10_1016_S0960_894X_01_00571_6
11591521
14083583
S0960894X01005716
Genre Journal Article
GroupedDBID ---
--K
--M
.HR
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6TJ
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABTAH
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D0L
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LZ2
M29
M2Z
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCB
SCC
SDF
SDG
SDP
SES
SEW
SOC
SPC
SPCBC
SPT
SSH
SSK
SSP
SSU
SSZ
T5K
WUQ
XFK
XPP
Y6R
YK3
ZMT
ZY4
~02
~G-
ABPIF
ABPTK
IQODW
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
7X8
ID FETCH-LOGICAL-c457t-ab82b3150adc557605a4d192b4e76c49eb7e1841023a4e2e54d5e628d43e56973
ISSN 0960-894X
IngestDate Fri Oct 25 23:05:30 EDT 2024
Thu Sep 26 18:55:30 EDT 2024
Sat Sep 28 08:38:08 EDT 2024
Sun Oct 22 16:04:37 EDT 2023
Fri Feb 23 02:24:01 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 20
Keywords Antineoplastic agent
Automation
Isoxazole derivatives
Enzyme
Transferases
Combinatorial chemistry
Enzyme inhibitor
In vitro
Signal transduction
Structure activity relation
Kinase
Chemical compound library
Benzenic compound
Ureas
Onc gene
Chemical synthesis
Oxygen nitrogen heterocycle
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c457t-ab82b3150adc557605a4d192b4e76c49eb7e1841023a4e2e54d5e628d43e56973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 11591521
PQID 72184611
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_72184611
crossref_primary_10_1016_S0960_894X_01_00571_6
pubmed_primary_11591521
pascalfrancis_primary_14083583
elsevier_sciencedirect_doi_10_1016_S0960_894X_01_00571_6
PublicationCentury 2000
PublicationDate 2001-10-22
PublicationDateYYYYMMDD 2001-10-22
PublicationDate_xml – month: 10
  year: 2001
  text: 2001-10-22
  day: 22
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Bioorganic & medicinal chemistry letters
PublicationTitleAlternate Bioorg Med Chem Lett
PublicationYear 2001
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Naumann, Eisenmann-Tappe, Rapp (BIB3) 1997; 143
BIB17
Dumas (BIB8) 2001; 11
GK 00687, Maybridge Chemical Company Ltd., Trevillett, Tintagel, Cornwall, UK
Monia, Johnston, Geiger, Muller, Fabbro (BIB4) 1996; 2
Tang, McMahon (BIB9) 1997; 126
,
163040.
Bos (BIB2) 1989; 49
Dumas, Sibley, Riedl, Monahan, Lee, Lowinger, Redman, Johnson, Kingery-Wood, Scott, Smith, Bobko, Schoenleber, Ranges, Housley, Bhargava, Wilhelm, Shrikhande, Dumas, Hatoum-Mokdad, Sibley, Riedl, Scott, Monahan, Lowinger, Brennan, Natero, Turner, Johnson, Schoenleber, Bhargava, Wilhelm, Housley, Ranges, Shrikhande (BIB10) 2000; 10
BIB12
BIB13
MacDonald, Crews, Wu, Driller, Clark, Erikson, McCormick (BIB16) 1993; 13
BIB14
BIB15
Redman, Johnson, Dally, Swartz, Wild, Paulsen, Caringal, Gunn, Renick, Osterhout, Kingery-Wood, Smith, Lee, Dumas, Wilhelm, Housley, Bhargava, Ranges, Shrikhande, Young, Bombara, Scott (BIB7) 2001; 11
Wood, J. E.; Wild, H.; Rogers, D. H.; Lyons, J.; Katz, M.; Caringal, Y.; Dally, R.; Lee, W.; Smith, R. A.; Blum, C. U.S. Patent 6 187 799, 2001
Lowy, Willumsen (BIB1) 1993; 62
Lackey, Cory, Davis, Frye, Harris, Hunter, Jung, McDonald, McNutt, Peel, Rutkowske, Veal, Wood (BIB5) 2000; 10
Tang (10.1016/S0960-894X(01)00571-6_BIB9) 1997; 126
Naumann (10.1016/S0960-894X(01)00571-6_BIB3) 1997; 143
MacDonald (10.1016/S0960-894X(01)00571-6_BIB16) 1993; 13
Lackey (10.1016/S0960-894X(01)00571-6_BIB5) 2000; 10
Redman (10.1016/S0960-894X(01)00571-6_BIB7) 2001; 11
Dumas (10.1016/S0960-894X(01)00571-6_BIB10_1) 2000; 10
10.1016/S0960-894X(01)00571-6_BIB6
10.1016/S0960-894X(01)00571-6_BIB11
(10.1016/S0960-894X(01)00571-6_BIB8_2) 1998; 8
Lowy (10.1016/S0960-894X(01)00571-6_BIB1) 1993; 62
Dumas (10.1016/S0960-894X(01)00571-6_BIB10_2) 2000; 10
Dumas (10.1016/S0960-894X(01)00571-6_BIB8_1) 2001; 11
Monia (10.1016/S0960-894X(01)00571-6_BIB4) 1996; 2
Bos (10.1016/S0960-894X(01)00571-6_BIB2) 1989; 49
References_xml – volume: 49
  start-page: 4682
  year: 1989
  ident: BIB2
  publication-title: Cancer Res.
  contributor:
    fullname: Bos
– volume: 13
  start-page: 6615
  year: 1993
  ident: BIB16
  publication-title: Mol. Cell Biol.
  contributor:
    fullname: McCormick
– volume: 11
  start-page: 9
  year: 2001
  ident: BIB7
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Scott
– ident: BIB13
– ident: BIB12
– volume: 143
  start-page: 237
  year: 1997
  ident: BIB3
  publication-title: Rec. Results Cancer Res.
  contributor:
    fullname: Rapp
– ident: BIB17
– volume: 62
  start-page: 851
  year: 1993
  ident: BIB1
  publication-title: Annu. Rev. Biochem.
  contributor:
    fullname: Willumsen
– volume: 2
  start-page: 668
  year: 1996
  ident: BIB4
  publication-title: Nature Med.
  contributor:
    fullname: Fabbro
– ident: BIB14
– volume: 10
  start-page: 223
  year: 2000
  ident: BIB5
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Wood
– volume: 10
  start-page: 2047
  year: 2000
  ident: BIB10
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Shrikhande
– ident: BIB15
– volume: 126
  start-page: 139849
  year: 1997
  ident: BIB9
  article-title: PCT Intl. Appl. WO 96/40673
  publication-title: Chem. Abstr.
  contributor:
    fullname: McMahon
– volume: 11
  start-page: 405
  year: 2001
  ident: BIB8
  publication-title: Exp. Opin, Ther. Pat.
  contributor:
    fullname: Dumas
– volume: 10
  start-page: 2051
  year: 2000
  ident: 10.1016/S0960-894X(01)00571-6_BIB10_2
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(00)00272-9
  contributor:
    fullname: Dumas
– volume: 10
  start-page: 223
  year: 2000
  ident: 10.1016/S0960-894X(01)00571-6_BIB5
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(99)00668-X
  contributor:
    fullname: Lackey
– volume: 13
  start-page: 6615
  year: 1993
  ident: 10.1016/S0960-894X(01)00571-6_BIB16
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.13.11.6615
  contributor:
    fullname: MacDonald
– volume: 11
  start-page: 9
  year: 2001
  ident: 10.1016/S0960-894X(01)00571-6_BIB7
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(00)00574-6
  contributor:
    fullname: Redman
– volume: 8
  start-page: 1749
  year: 1998
  ident: 10.1016/S0960-894X(01)00571-6_BIB8_2
  publication-title: Exp. Opin. Ther. Pat.
  doi: 10.1517/13543776.8.12.1749
– volume: 49
  start-page: 4682
  year: 1989
  ident: 10.1016/S0960-894X(01)00571-6_BIB2
  publication-title: Cancer Res.
  contributor:
    fullname: Bos
– volume: 2
  start-page: 668
  year: 1996
  ident: 10.1016/S0960-894X(01)00571-6_BIB4
  publication-title: Nature Med.
  doi: 10.1038/nm0696-668
  contributor:
    fullname: Monia
– ident: 10.1016/S0960-894X(01)00571-6_BIB11
  doi: 10.1016/S0960-894X(01)00571-6
– volume: 143
  start-page: 237
  year: 1997
  ident: 10.1016/S0960-894X(01)00571-6_BIB3
  publication-title: Rec. Results Cancer Res.
  doi: 10.1007/978-3-642-60393-8_16
  contributor:
    fullname: Naumann
– volume: 126
  start-page: 139849
  year: 1997
  ident: 10.1016/S0960-894X(01)00571-6_BIB9
  article-title: PCT Intl. Appl. WO 96/40673
  publication-title: Chem. Abstr.
  contributor:
    fullname: Tang
– ident: 10.1016/S0960-894X(01)00571-6_BIB6
– volume: 10
  start-page: 2047
  year: 2000
  ident: 10.1016/S0960-894X(01)00571-6_BIB10_1
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(00)00270-5
  contributor:
    fullname: Dumas
– volume: 62
  start-page: 851
  year: 1993
  ident: 10.1016/S0960-894X(01)00571-6_BIB1
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.bi.62.070193.004223
  contributor:
    fullname: Lowy
– volume: 11
  start-page: 405
  year: 2001
  ident: 10.1016/S0960-894X(01)00571-6_BIB8_1
  publication-title: Exp. Opin, Ther. Pat.
  doi: 10.1517/13543776.11.3.405
  contributor:
    fullname: Dumas
SSID ssj0014044
Score 2.025737
Snippet Heterocyclic ureas, such as N-3-thienyl N′-aryl ureas, have been identified as novel inhibitors of raf kinase, a key mediator in the ras signal transduction...
Heterocyclic ureas, such as N-3-thienyl N'-aryl ureas, have been identified as novel inhibitors of raf kinase, a key mediator in the ras signal transduction...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 2775
SubjectTerms Antineoplastic agents
Biological and medical sciences
General aspects
Medical sciences
Pharmacology. Drug treatments
Proto-Oncogene Proteins c-raf - antagonists & inhibitors
Structure-Activity Relationship
Urea - analogs & derivatives
Urea - chemical synthesis
Urea - chemistry
Urea - pharmacology
Title Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach
URI https://dx.doi.org/10.1016/S0960-894X(01)00571-6
https://www.ncbi.nlm.nih.gov/pubmed/11591521
https://search.proquest.com/docview/72184611
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6TgIkhKBjUC7DDwiBqoxcnBtvpSsaSPDAhrS3yIkdEW0kU7M-9KfwbznHTuwGMXGRkKKodX2pcr7Y3zk-x4eQ52VSumUSS8fzBaYwCwMnZ3iKqEzzOOZRKpSX7_FJ_OksOVqy5WjUJ2m1Zf9V0lAGssbI2b-QtukUCuAzyBzuIHW4_5Hcj6q2QLfMjaaB8NiaYlPgUdba_xwvzCM-K5A3Y6UVL2fnVQ3L2ayqv1Z5hQl40FJQic6VyNBKPmtRgRaYeFl22LkAlCCJ5eieDno2avFohi_6VHLm3PLBBnLV6IRShQJft8U_aHahIo0M5zc2oM8NRipv2WBXedNal19T3qVwXmCE48zYuN82-XnTRyl1vfRWD-V251sd2YTjWN8nZdOMXCdJtcvnodQzOouYEzA3HEz53ha0fXd7Ao91IpeODMDX5JcLjbZ5nJgRQR3AlAcpBvd6zk-Heyu6oOpiVdCAsVK0Q3Z9mB3ZmOzO3y_PPpjNL-aqHMSmbxt49toO-NL1XnWDXUepbl_yFl70UmdouV6FUlTq9C650-lAdK7Be4-MZD0he3NEzrcNfUGVV7La7pmQm4seDxNy42PnCLJHvhuY06ak2zCnCuYULwowpwrmWAlgTjXMqYX5GzoEOVbkVIOcWpBTBDnNN_DbAOTUoJX2IL9Pvrxbni6OnS7LiFOwML5yeJ74eQB6ERdFCNq3G3ImQO_JmYyjgqUyj6WXMDzihDPpy5CJUEZ-IlggwyiNg30yrptaPiQ05GnChRfGuDAKHnLOkJGLiKWJEH48JYe9oLJLfZhMZr0sQbIZSjZzvUxJNoumJOnFmXWMWDPdDHD4u6YHA_HbARlqXUkwJc96PGTwpHCfkNeyWbdZjGafyPOm5IGGiW0Lyg8S_kf__r8ek1v2fX5CxlertXxKdlqxPujegx8USvbz
link.rule.ids 315,782,786,27934,27935
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Discovery+of+heterocyclic+ureas+as+a+new+class+of+raf+kinase+inhibitors%3A+identification+of+a+second+generation+lead+by+a+combinatorial+chemistry+approach&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Smith%2C+Roger+A&rft.au=Barbosa%2C+James&rft.au=Blum%2C+Cheri+L&rft.au=Bobko%2C+Mark+A&rft.date=2001-10-22&rft.pub=Elsevier+Ltd&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=11&rft.issue=20&rft.spage=2775&rft.epage=2778&rft_id=info:doi/10.1016%2FS0960-894X%2801%2900571-6&rft.externalDocID=S0960894X01005716
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon